COMMUNIQUÉS West-GlobeNewswire

miRagen Therapeutics, Inc. Prices Public Offering of Common Stock
09/02/2018
BOULDER, Colo., Feb. 08, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today [...]
FDA Grants Orphan Drug Designation (ODD) for Xeris Pharmaceuticals' Ready-to-Use Glucagon for the Treatment of Hyperinsulinemic Hypoglycemia (HH). Results from Phase 2a Study in Post-Bariatric Hypoglycemia, Associated with HH, Published.
09/02/2018
Chicago, IL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]
Aclaris Therapeutics to Present Data on ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) at the 2018 American Academy of Dermatology Annual Meeting
08/02/2018
ESKATA™ received FDA approval for the treatment of raised seborrheic keratoses (SKs) in December 2017 WAYNE, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led [...]
Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
08/02/2018
TUCSON, Ariz., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial results for 2017. President [...]
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
08/02/2018
MEDFORD, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI ) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it has commenced an [...]
Chembio Diagnostics Announces Major New Tender Win and Certain Preliminary 2017 Financial Results
08/02/2018
MEDFORD, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI ) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it has won a three-year [...]
BioStem Technologies Adds Chief Revenue Officer to Executive Team
08/02/2018
Pompano Beach, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies [...]
Aduro Biotech to Present at the Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
BERKELEY, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the Leerink [...]
AzurRx BioPharma to Present at the 2018 BIO CEO & Investor Conference (February 12th)
08/02/2018
BROOKLYN, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
CRISPR Therapeutics Announces Transition of Bill Lundberg, MD
08/02/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP ), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]
The Ensign Group Reports Fourth Quarter and Fiscal Year 2017 Results
08/02/2018
MISSION VIEJO, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]
The Cooper Companies Announces Release Date for First Quarter 2018
08/02/2018
PLEASANTON, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced it will release first quarter 2018 financial results on Thursday, March 8, 2018, at 4:15 PM ET. Following the [...]
Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update
08/02/2018
Presented Compelling Results with Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer (mTNBC) at San Antonio Breast Cancer Symposium Secured $250 Million Funding to Support Company’s Next Growth Phase [...]
Ascendis Pharma A/S Announces Participation in Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
COPENHAGEN, Denmark, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare [...]
Five Prime Therapeutics to Present at LEERINK Partners 7th Annual Global Healthcare Conference
08/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (Nasdaq: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today [...]
Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress
08/02/2018
Fluidigm Posts Sequential and Year-Over-Year Quarterly Revenue Growth 2017 Highlights Include Launch of Hyperion Imaging System, Licensing and Distribution Partnerships, Improved Balance Sheet, Double-Digit Operating [...]
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017
08/02/2018
PORTLAND, Maine, Feb. 08, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC ) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Organovo Announces Fiscal Third-Quarter 2018 Results; Company Updates Full-Year Fiscal 2018 Outlook
08/02/2018
SAN DIEGO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today reported financial results for the fiscal third quarter of 2018 and updated its full-year fiscal 2018 outlook. The [...]
Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights
08/02/2018
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Pages